Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening

Journal of Epidemiology and Community Health

Volumn 70, Issue 1, 2015, Pages 72-77

  Labani, Satyanarayana ^a   Asthana, Smita ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AGE CLASS; CANCER; DETECTION METHOD; DNA; HEALTH CARE; HEALTH RISK; MEDICAL GEOGRAPHY; REPRODUCTIVE HEALTH; RURAL POPULATION; VIRAL DISEASE; VISUAL ANALYSIS;

INDIA;

HUMAN PAPILLOMAVIRUS;

ACETIC ACID; VIRUS DNA;

ADULT; AGE; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

ACETIC ACID; ADULT; AGE FACTORS; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84958107240     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2015-205851     Document Type: Article

References (32)

1. Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003; 95:E2.
2. Leinonen MK, Anttila A, Malila N, et al. Type-and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland. Br J Cancer 2013;109:2941-50.
3. Gravitt PE, Paul P, Katki HA, et al. Effectiveness of VIA, Pap, and HPV DNA testing in a Cervical Cancer Screening Program in a Peri-Urban Community in Andhra Pradesh, India. PLoS ONE 2010;5:e13711. (accessed 3 Mar 2013).
4. Almonte M, Ferreccio C, Winkler JL, et al. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 2007;121:796-802.
5. Zong LJ, Zhang YZ, Yang XS, et al. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China. Asian Pac J Cancer Prev 2015;16:1907-12.
6. Sarian LO, Derchain SF, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing ascervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMericanScreening) study. J Med Screen 2005;12:142-9.
7. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385-94.
8. Koliopoulos G, Arbyn M, Martin-Hirsch P, et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 2007;104:232-46.
9. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:530-5.
10. Safaeian M, Kiddugavu M, Gravitt PE, et al. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis 2007;34:429-36.
11. Snijders PJ, Verhoef VM, Arbyn M, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013;132:2223-36.
12. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012;104:178-88.
13. Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172-83.
14. Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol Biomarkers Prev 2015;24:769-72.
15. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
16. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
17. Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomised setting. J Natl Cancer Inst 2009;101:1612-23.
18. Zhao FH, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010;11:1160-71.
19. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-36.
20. Jeronimo J, Bansil P, Lim J, et al. A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int J Gynecol Cancer 2014;24:576-85.
21. Labani S, Asthana S, Sodhani P, et al. CareHPV cervical cancer screening demonstration in a rural population of north India. Eur J Obstet Gynecol Reprod Biol 2014;176:75-9.
22. Ngou J, Magooa MP, Gilham C, et al. Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women. J Clin Microbiol 2013;51:4240-2.
23. Lin CQ, Chen F, Liu B, et al. A parallel study of careHPV and Hybrid Capture 2 human papillomavirus DNA testing for cervical cancer screening in rural China. J Virol Methods 2014;202:73-8.
24. Labani S, Asthana S. Human papillomavirus viral load on careHPV testing of self-collected vaginal samples vs. clinician-collected cervical samples. Eur J Obstet Gynecol Reprod Biol 2014;181:233-9.
25. Lorenzi AT, Fregnani JH, Possati-Resende JC, et al. A Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test. Gynecol Oncol 2013;131:131-4.
26. Asthana S, Labani S. Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia. Cancer Epidemiol 2015;39:104-8.
27. Sellors JW, Sankaranarayanan R, eds. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual. Lyon: IARC, 2003.
28. Sankaranarayanan R, Ramani S, Wesley. A practical manual on visual screening for cervical neoplasia. International Agency for Research on Cancer. Lyon, France: IARC Technical Publication no. 41 IARC Press Lyon, 2003. http://screening.iarc.fr/viaviliforeword.php?lang=1(accessed3 Jul 2014).
29. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008;123:153-60.
30. Ronco G, Giorgi-Rossi P, Carozzi F, et al., New Technologies for Cervical Cancer screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57.
31. Sankaranarayanan R, Chatterji R, Shastri SS, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004;112:341-7.
32. Asthana S, Labani S. Factors associated with attitudes of rural women toward cervical cancer screening. Indian J Community Med 2013;38:246-8.